Conference Paper: A phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in patients with chronic hepatitis B infection

File Download Links for fulltext
(May Require Subscription)
  • Find via
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleA phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in patients with chronic hepatitis B infection
AuthorsYuen, RMF
Kim, J
Wong, DKH
Ngai, WS
Yuen, JCH
Lai, CL
Issue Date2003
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/antiviral
ISSN0166-3542
2011 Impact Factor: 4.301
2011 SCImago Journal Rankings: 0.393
DC Field
Value
dc.contributor.authorYuen, RMF
dc.contributor.authorKim, J
dc.contributor.authorWong, DKH
dc.contributor.authorNgai, WS
dc.contributor.authorYuen, JCH
dc.contributor.authorLai, CL
dc.date.accessioned2010-09-25T20:46:06Z
dc.date.available2010-09-25T20:46:06Z
dc.date.issued2003
dc.identifier.hkuros130912
dc.identifier.issn0166-3542
2011 Impact Factor: 4.301
2011 SCImago Journal Rankings: 0.393
dc.identifier.openurl
dc.identifier.urihttp://hdl.handle.net/10722/102819
dc.languageeng
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/antiviral
dc.relation.ispartofAntiviral Research
dc.rightsAntiviral Research. Copyright © Elsevier BV.
dc.titleA phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in patients with chronic hepatitis B infection
dc.typeConference_Paper